CVS Health Corporation $CVS Shares Sold by Candriam S.C.A.

Candriam S.C.A. reduced its stake in CVS Health Corporation (NYSE:CVS) by 16.4% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 190,958 shares of the pharmacy operator’s stock after selling 37,430 shares during the quarter. Candriam S.C.A.’s holdings in CVS Health were worth $14,396,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Avion Wealth increased its stake in CVS Health by 99.0% during the second quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 189 shares during the period. Harbor Capital Advisors Inc. grew its holdings in shares of CVS Health by 72.1% in the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock valued at $26,000 after purchasing an additional 142 shares in the last quarter. Corundum Trust Company INC purchased a new stake in CVS Health during the 3rd quarter worth approximately $29,000. Harbor Asset Planning Inc. acquired a new stake in CVS Health during the 2nd quarter worth approximately $30,000. Finally, Front Row Advisors LLC boosted its position in CVS Health by 436.5% in the 2nd quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock valued at $31,000 after buying an additional 371 shares during the period. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on the company. Jefferies Financial Group increased their price objective on CVS Health from $92.00 to $98.00 in a research note on Thursday, October 30th. Truist Financial set a $100.00 price target on CVS Health in a research report on Wednesday, December 10th. Raymond James Financial upped their target price on shares of CVS Health from $75.00 to $90.00 in a research note on Friday, October 31st. The Goldman Sachs Group lifted their price target on shares of CVS Health from $93.00 to $95.00 and gave the stock a “buy” rating in a research note on Wednesday, December 10th. Finally, Cantor Fitzgerald reissued an “overweight” rating on shares of CVS Health in a research report on Wednesday, December 10th. Nineteen research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $94.82.

CVS Health Stock Down 2.9%

CVS stock opened at $76.06 on Tuesday. The stock has a market cap of $96.55 billion, a P/E ratio of 200.16, a PEG ratio of 0.72 and a beta of 0.50. The company has a current ratio of 0.83, a quick ratio of 0.63 and a debt-to-equity ratio of 0.83. CVS Health Corporation has a twelve month low of $53.36 and a twelve month high of $85.15. The company’s 50 day moving average is $78.56 and its two-hundred day moving average is $75.87.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, February 2nd. Shareholders of record on Thursday, January 22nd were issued a dividend of $0.665 per share. The ex-dividend date of this dividend was Thursday, January 22nd. This represents a $2.66 annualized dividend and a dividend yield of 3.5%. CVS Health’s dividend payout ratio (DPR) is presently 700.00%.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.